Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
Daniele Caracciolo(Magna Graecia University), Pierfrancesco Tassone(Magna Graecia University), Simona Sestito(Magna Graecia University), Anna Ferrari(University of Bologna), Cirino Botta(Ospedale Annunziata di Cosenza), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Pierpaolo Correale(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Eugénie Duroyon, Antonio Giordano(University of Siena), Maria Teresa Di Martino(Centro Clinico Nemo), Francesca Scionti(Magna Graecia University), Francesco Conforti, Emanuela Altomare(Magna Graecia University), Gabriella Talarico(Azienda Ospedaliera Pugliese Ciaccio), Katia Grillone(Magna Graecia University), Vahid Asnafi(Hôpital Necker-Enfants Malades), Andrea Biondi(University of Milano-Bicocca), Gaetanina Golino(Institute of Oncology Research), Licia Pensabene(Magna Graecia University), Marco Rossi(Magna Graecia University), Caterina Riillo(Magna Graecia University), Beatrice Belmonte(University of Palermo), Greta Alampi(University of Milano-Bicocca), Ludovic Lhermitte(Hôpital Necker-Enfants Malades), Markus Hildinger, Chiara Buracchi(Fondazione Humanitas per la Ricerca), Alessandro Gulino(University of Palermo), Giovanni Martinelli(University of Bologna), Mariamena Arbitrio(Institute for Biomedical Research and Innovation), Andrea Ballerini, Nicoletta Polerà(Magna Graecia University), Giada Juli(University of Rome Tor Vergata), Daniela Concolino(Magna (Austria)), Giuseppe Gaipa(University of Milano-Bicocca), Massimo Martino(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Claudio Tripodo(University of Palermo), Pierosandro Tagliaferri(Magna Graecia University), Michelangelo Iannone, Maria Eugenia Gallo Cantafio(Magna Graecia University)
Cited by 26
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k